They showed that the activation of the SphK1/NF-κB/FSCN1 pathway was associated with poor patient survival and distance metastasis, whereas inhibition of SphK1 or NF-κB remarkably inhibited tumor growth and lung metastasis in a TNBC mouse model [67]. Here, SPHK1 is linked to neoplasm.